accountDOW JONES NEWSWIRES King Pharmaceuticals Inc.(KG) swung to a first-quarter loss on acquisition- related costs as branded-drug sales skidded, with its once top-seller Altace blood-pressure drug tumbling amid generic competition. But earnings excluding...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to King Pharma Swings To 1Q Loss On Acquisition Charges
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account